Research
The “Keta APP”
KRF is in the process of creating a unique and comprehensive APP that will provide virtually all relevant information about ketamine and KAP titled the “Keta APP. This is an advanced AI innovation project, interactive in nature, containing information from all of Wolfson’s work and carefully selected contributions from other practitioners, with attributions. Additionally, it contains our Ketamine Guidelines as a resource.
The KAP Clinical Review
As the creator and initiator of KAP, we published our study of 235 patients in 2019. It remains the cornerstone of KAP’s success story. In the intervening years, we have accumulated experience and data for over 1000 additional patients, digitized in Vanderbilt University’s Redcap program, making it highly accessible for us to publish a major new report to the field. This project entails completing the patient charts under HIPAA compliance and with our statistician compiling the data and its presentation for a paper that in high detail reflects KAP practice.
The Phantom Limb Pain Protocol—FDA and IRB-approved.
We have begun subject accrual for what we believe to be of great benefit to those suffering from the physical and emotional aftermaths of trauma and amputations. Our goal is to establish the protocol for application worldwide.
Ketamine has indications for potential benefit for a variety of pain disorders, including phantom limb pain. Based on a compelling anecdote (our story appearing in Lucid News), we are conducting a proof-of-concept study to assess ketamine’s potential benefit for this syndrome, which causes so much suffering.